Ex Parte Ahrens et alDownload PDFPatent Trial and Appeal BoardMay 13, 201311420055 (P.T.A.B. May. 13, 2013) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE ____________________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________________ Ex parte MICHAEL AHRENS, ERIK O. MARTZ, RONALD BURKE, and BENJAMIN F. CARTER ____________________ Appeal 2011-003567 Application 11/420,055 Technology Center 3700 ____________________ Before: JAMES P. CALVE, SCOTT A. DANIELS, and BEVERLY M. BUNTING, Administrative Patent Judges. BUNTING, Administrative Patent Judge. DECISION ON APPEAL Appeal 2011-003567 Application 11/420,055 2 STATEMENT OF CASE Appellants appeal under 35 U.S.C. § 134 from a rejection of claims 1- 3, 16, 23-25, 29-31, 42-48, 50, 54-59 and 63. We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. CLAIMED SUBJECT MATTER The claims are directed to a mold assembly for an intervertebral prosthesis. Claims 1 and 63 are independent. Claim 1, reproduced below, is illustrative of the claimed subject matter: 1. A mold assembly for in situ formation of a resilient prosthesis in an intervertebral disc space between adjacent vertebrae of a patient, the mold assembly comprising: at least a first mold having at least one interior cavity located in the intervertebral disc space; at least a first lumen having a distal end fluidly coupled to the mold at a first location; one or more discrete reinforcing structures functionally centered in the intervertebral disc space with the mold; one or more resilient, in situ curable resilient biomaterials delivered to the interior cavity through the first lumen in an uncured form, substantially encapsulating the reinforcing structure, the at least partially in situ cured biomaterials, the reinforcing structures, and the mold cooperating to comprise the resilient prosthesis; and the resilient prosthesis comprising a resilient interface between the adjacent vertebrae. REFERENCES The prior art relied upon by the Examiner in rejecting the claims on appeal is: Felt Gerber US 5,556,429 US 2005/0251260 A1 Sep. 17, 1996 Nov. 10, 2005 Appeal 2011-003567 Application 11/420,055 3 Guinan Cheng Hudgins US 7,083,639 B2 US 2007/0093903 A1 US 2007/0093906 A1 Aug. 1, 2006 Apr. 26, 2007 Apr. 26, 2007 REJECTIONS The Examiner made the following rejections: Claims 1-3, 23-25, 30, 31, 47, 48, 55, 56, 58, 59 and 63 stand rejected under 35 U.S.C. § 103(a) as being unpatentable over Gerber and Felt. Ans. 3. Claims 16 and 42 stand rejected under 35 U.S.C. § 103(a) as being unpatentable over Gerber, Felt and Guinan. Ans. 5. Claims 1-3, 23-25, 29-31, 43, 46-48, 50, 54, 57-59 and 63 stand rejected under 35 U.S.C. § 103(a) as being unpatentable over Hudgins and Felt. Ans. 6. Claims 16, 42, 44 and 45 stand rejected under 35 U.S.C. § 103(a) as being unpatentable over Hudgins, Felt, and Guinan. Ans. 8. Claims 55 and 56 stand rejected under 35 U.S.C. § 103(a) as being unpatentable over Hudgins, Felt and Cheng. Ans. 9. ANALYSIS Obviousness Rejections Claims 1-3, 23-25, 30, 31, 47, 48, 55, 56, 58, 59 and 63, Gerber and Felt Appellants argue claims 1-3, 23-25, 30, 31, 47, 48, 55, 56, 58, 59 and 63 as a group. App. Br. 3-4. We select claim 1 as representative of the group. See 37 C.F.R. § 41.37(c)(1)(vii) (2011). Appeal 2011-003567 Application 11/420,055 4 Claim 1 describes a mold assembly for in situ formation of prosthesis in an intervertebral space between adjacent vertebrae using an in situ curable biomaterial. The Examiner found that Gerber discloses a mold assembly that includes a first lumen valve, one or more discrete reinforcing structures, and one or more resilient biomaterials, for in situ formation of a resilient prosthesis in an intervertebral space between adjacent vertebrae of a patient. Ans. 3-4; citing Gerber paras. [0079], [0080] and [0082]. While acknowledging that Gerber does not discuss a biomaterial that at least partially cures in situ, the Examiner relied on Felt for this teaching. Ans. 4; citing Felt, Abstract. The Examiner reasoned that it would have been obvious to “incorporate the injection of the curable biomaterial of Felt with the device of Gerber et al. due to the fact that a less invasive surgery can be provided by using such a material.” Ans. 4-5; citing Felt, col. 2, ll. 18-23. Appellants argue that the articulated reason provided by the Examiner fails to provide a basis for combining the teachings of Gerber and Felt, since “the implantation procedure of Gerber is not made less invasive by substituting the curable biomaterial of Felt.” App. Br. 4. In support, Appellants assert that the rigid preformed endplates of Gerber require that the surgeon “create an opening in the intervertebral disc space to pass the endplates.” Id. Appellants also argue that Gerber does not suggest “[e]ncapsulating or functionally engaging the reinforcing structure with an in-situ curable biomaterial,” nor does Gerber suggest “injecting an in-situ curable biomaterial into the implant.” Id. These arguments do not persuade us of error in the Examiner’s findings. As the Examiner correctly noted, Gerber specifically discloses that the intervertebral device can be used in a minimally invasive surgical Appeal 2011-003567 Application 11/420,055 5 method. Ans. 10; citing Gerber, paras. [0032], [0079] and [0080]. The Examiner reasonably explained that “implanting the device of Gerber before it is filled with a fluid, and then filling the device with the hydrogel mix of Felt (which falls within the scope of a fluid which is a gel) would provide for a less invasive surgery by allowing for a smaller incision.” Ans. 11; citing Gerber, para. [0080]. Further, the Examiner correctly pointed to Gerber’s teaching of “filling space 26 of disc 10 with a fluid (including gas, liquid, gel, or a combination thereof) thereby encapsulating the spring component 30 with the fluid” in support of a modification to encapsulate the spring component. Ans. 11; citing Gerber, para. [0079]. The Examiner’s reason to combine the teachings of Gerber and Felt is expressly articulated and supported by rational underpinnings. In re Kahn, 441 F.3d 977, 988 (Fed. Cir. 2006), cited with approval in KSR Int'l Co. v. Teleflex, Inc., 550 U.S. 398, 418 (2007). Therefore, we sustain the rejection of claim 1 and claims 2, 3, 23-25, 30, 31, 47, 48, 55, 56, 58, 59 and 63 which depend therefrom. Claims 16 and 42 Gerber, Felt and Guinan Claims 16 and 42 depend from claim 1. Appellants do not provide a separate argument in addressing the rejection of claims 16 and 42, and rely on the argument provided with respect to claim 1. App. Br. 5. For the reasons discussed supra with respect to claim 1, we likewise sustain the rejection of claims 16 and 42. Appeal 2011-003567 Application 11/420,055 6 Claims 1-3, 23-25, 29-31, 43, 46-48, 50, 54, 57-59, and 63, Hudgins and Felt Appellants argue claims 1-3, 23-25, 29-31, 43, 46-48, 50, 54, 57-59, and 63 as a group. App. Br. 3-4. We select claims 1 as representative of the group. The Examiner found that Hudgins likewise teaches a mold assembly for the formation of a resilient prosthesis, but does not teach a biomaterial that at least partially cures in situ. Ans. 6-8. Again, the Examiner relied on Felt to teach a spinal implant that includes the use of biomaterial that can be delivered and cured in situ. Ans. 8; citing Felt, Abstract. Based on these findings, the Examiner reasoned that it would have been obvious to “incorporate the injection of the curable biomaterial of Felt with the device of Hudgins et al. due to the fact that a less invasive surgery can be provided by using such a material.” Ans. 8; citing Felt, col. 2, ll. 18-23. Appellants limit their challenge to arguing that Hudgins is not prior art to the present invention and attempt to swear behind and thus remove Hudgins as a reference via “Declaration of Prior Invention under 37 C.F.R. § 1.131 filed on July 14, 2009 and a Supplemental 37 C.F.R. § 1.131 Declaration of Prior Invention (‘Supplemental Declaration’) filed on November 20, 2009.” 1 App. Br. 5. The Supplemental Declaration is signed 1 We note that Appellants’ Appeal Brief filed July 15, 2010 and Supplemental Appeal Brief filed August 3, 2010 do not include a copy of either the Declaration filed July 14, 2009 or Supplemental Declaration filed August 11, 2009 in the “Evidence Appendix” as required by 37 C.F.R. 41.37(c)(1)(ix). Since the Examiner entered the Supplemental Declaration into the record as indicated in the Office Communication dated September 4, 2009, and Appellants contested the Examiner’s adverse decision in the Arguments section of the Appeal Brief, we will consider the Supplemental Appeal 2011-003567 Application 11/420,055 7 by the inventors and includes Exhibits A through I (“Exhibits”) as evidence. Although the Examiner considered the Supplemental Declaration, the Examiner found that the Supplemental Declaration is “ineffective to overcome the Hudgins et al. reference” as required by 37 C.F.R. § 1.31. Ans. 12. 37 C.F.R. § 1.131 provides in relevant part:2 (a) When any claim of an application or a patent under reexamination is rejected, the inventor of the subject matter of the rejected claim, the owner of the patent under reexamination, or the party qualified under §§ 1.42, 1.43, or 1.47, may submit an appropriate oath or declaration to establish invention of the subject matter of the rejected claim prior to the effective date of the reference or activity on which the rejection is based …. (b) The showing of facts shall be such, in character and weight, as to establish reduction to practice prior to the effective date of the reference, or conception of the invention prior to the effective date of the reference coupled with due diligence from prior to said date to a subsequent reduction to practice or to the filing of the application. Original exhibits of drawings or records, or photocopies thereof, must accompany and form part of the affidavit or declaration or their absence must be satisfactorily explained. 37 C.F.R. § 1.131 (2008). To definitively swear behind Hudgins, Appellants must establish invention of the subject matter of the rejected claims prior to the effective date of Hudgins by showing facts sufficient to establish reduction to practice prior to the effective date or conception of the invention prior to the effective date coupled with due diligence from prior to each effective date to a Declaration filed August 11, 2009 (and presume Appellants erroneously cited the filing date on page 5 of the Appeal Brief). 2 The Appeal Brief was filed prior to the August 12, 2012 change to 37 C.F.R. § 1.131; therefore the rule in effect on the filing date is applied. Appeal 2011-003567 Application 11/420,055 8 subsequent reduction to practice or to the filing of the application. 37 C.F.R. § 1.131. At the outset, we note that Appellants do not contest that the effective date of Hudgins under 35 U.S.C. § 103(a) is October 26, 2005 in the Supplemental Declaration or Appeal Brief. Supp. Decl. para. 1; App. Br. 5. Thus, to be effective in antedating Hudgins as a reference, the Supplemental Declaration must establish reduction to practice prior to October 26, 2005, or conception of the invention prior to that date coupled with due diligence to a subsequent reduction to practice or to the filing of the Appellant’s application on May 24, 2006. We observe that the Supplemental Declaration alleges “completion in the United States of the inventions claimed in the above-identified application before October 26, 2005” and refers to Exhibits A, B and C as evidence of conception prior to October 26, 2005. Supp. Decl. paras. 1-6; App. Br. 5. Further, the Supplemental Declaration alleges that Exhibits A and C include disclosure “supporting at least claims 1 and 63 of the present invention.” Supp. Decl. paras. 4 and 6. A careful review of the Declaration reveals that the Declaration fails to address the claim limitations of “at least claims 1 and 63”; nor does the Declaration address any of the dependent claims with any specificity. The evidence submitted by the Appellants in the present appeal is similar in weight and character to the evidence submitted in In re Borokowski, 505 F.2d 713 (CCPA 1974) and In re Harry, 333 F.2d 920, 921 (CCPA 1964). In both of those cases, the court found the evidence insufficient to antedate the prior art.3 3 In In re Borokowski, 505 F.2d 713 (CCPA 1974), the appellants submitted a Rule 131 affidavit to antedate a prior art patent. Id. at 714. The appellants asserted that they conceived and reduced to practice the disclosed Appeal 2011-003567 Application 11/420,055 9 and claimed subject matter prior to the filing date of the prior art patent. Id. at 716. The remainder of the affidavit referred to attached exhibits, including notebook pages and laboratory data, which the appellants asserted described a reduction to practice of the process of the application. Id. The appellants also submitted a supplemental affidavit with a supplemental progress report discussing the significance of the test runs described in the earlier-submitted exhibits. Id. at 717. In determining that the original and supplemental affidavits were insufficient to antedate the prior art reference, the court in Borokowski stated: The original and supplemental affidavits together with the accompanying comments do not adequately explain what facts or data appellants are relying upon to show a completion of their invention prior to [the effective date of the prior art]. The affidavits for the most part consist of vague and general statements in the broadest terms as to what the exhibits show along with the assertion that the exhibits describe a reduction to practice. This amounts essentially to mere pleading, unsupported by proof or showing of facts. Id. at 718 (citing In re Harry, 333 F.2d 920 (CCPA 1964)). In particular, the court found that the fifteen notebook pages submitted in the exhibits to the original affidavit were not clear on their face and that “[i]t was appellants’ burden to explain the content of these notebook pages as proof of acts amounting to reduction to practice.” Id. at 719. The court concluded that “[a]bsent a clear explanation of the [pertinent] notebook pages pointing out exactly what facts are established therein and relied on by appellants, the affidavits based thereon are of little assistance in enabling the Patent Office and its reviewing courts to judge whether there was an actual reduction to practice of the invention.” Id. (citing In re Harry, supra). The court in Borokowski acknowledged that differences exist between the requirements of interference practice and the ex parte showing of completion of an invention prior to the effective date of a patent or publication under Rule 131; nonetheless, the court upheld the Board’s determination that the affidavits submitted in the case were insufficient to meet the requirements of Rule 131. Id. (stating that the court’s holding in In re Spiller, 500 F.2d 1170 (CCPA 1974), “nowhere weakens the requirement, under Rule 131, of a factual showing of completion of the invention before the critical date.”). Appeal 2011-003567 Application 11/420,055 10 In the case before us, the Supplemental Declaration consists of only a bald assertion in the broadest terms that the invention of “at least claims 1 and 63” was conceived of prior to the effective date. Appellants rely on Exhibits A-C submitted with the Supplemental Declaration as evidence in support of this assertion. However, as in Borokowski and Harry, the Supplemental Declaration also fails to sufficiently explain the content of the Exhibits or how the information therein establishes acts amounting to conception and diligent reduction to practice of the claimed invention. Thus, Appellants’ assertion of prior invention amounts to mere pleading unsupported by proof or showing of facts of sufficient character and weight to establish prior invention by Appellants. In re Borokowski, 505 F.2d at 718. Further, Appellants have failed to point to specific information within the identified Exhibits which they rely on to show conception of the invention. Neither the Supplemental Declaration nor the arguments in the Appeal Brief establish facts sufficient to tie the information found in the Exhibits to the claim limitations of “at least claims 1 and 63” in a manner to Similarly, in In re Harry, 333 F.2d at 921, the appellant filed two affidavits attempting to antedate prior art references. The first affidavit stated that the subject matter of a drawing annexed “was diligently reduced to practice,” and the second affidavit stated that “steps were taken to reduce the invention to practice in a commercial size unit by engineering preparation of drawings, cost estimates and both construction and installation of apparatus embodying the invention was done as promptly as possible in all the circumstances.” Id. at 922. The court held that Rule 131 requires “not a statement that facts exist” but an “oath to facts showing a completion of the invention” and “the showing of facts shall be such, in character and weight, as to establish reduction to practice, etc.” Id. The court found that the appellant’s affidavits were “not proof or ‘showing of facts’ but mere pleading” and merely asserted “that facts exist but does not tell what they are or when they occurred.” Id. Appeal 2011-003567 Application 11/420,055 11 show conception of even the basic invention.4 The attached Exhibits are of little assistance in enabling the Patent Office to judge whether there was conception of the invention prior to the effective date of the prior art and diligence thereafter until Appellants’ constructive reduction to practice. As such, the Supplemental Declaration and accompanying Exhibits do not establish a date of conception of every feature recited in the claims prior to the effective date of Hudgins as required by 37 C.F.R. § 1.131. Since Appellants have not established conception, we do not address whether Appellants established due diligence to reduce the invention to practice. Accordingly, the rejection of claims, 1-3, 23-25, 29-31, 43, 46-48, 50, 54, 57-59, and 63 is sustained. Claims 16,42,44 and 45 Hudgins, Felt and Guinan Claims 16, 42, 44 and 45 depend directly or indirectly from claim 1. Appellants do not provide a separate argument in addressing the rejection of claims 16, 42, 44 and 45, and rely on the argument provided with respect to claim 1. App. Br. 6. For the reasons discussed supra with respect to claim 1, we likewise sustain the rejection of claims 16, 42, 44 and 45. Claims 55 and 56, Hudgins, Felt and Cheng Claims 55 and 56 depend directly from claim 1. Appellants do not provide a separate argument in addressing the rejection of claims 55 and 56, and rely on the argument provided with respect to claim 63.5 App. Br. 6. 4 See In re Spiller, 500 F.2d 1170, 1178 (CCPA 1974) (holding a Rule 131 declaration that shows reduction to practice of the inventor’s “basic invention” is also sufficient as to claims differing therefrom in details which are obvious to one of ordinary skill in the art). 5 We note that claims 55 and 56 depend from claim 1. Appeal 2011-003567 Application 11/420,055 12 For the reasons discussed supra with respect to both claims 1 and 63, we likewise sustain the rejection of claims 55 and 56. DECISION The rejection of claims 1-3, 16, 23-25, 29-31, 42-48, 50, 54-59 and 63 is affirmed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(1)(iv) (2009). AFFIRMED mls Copy with citationCopy as parenthetical citation